ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
6 hedge funds and large institutions have $4.36M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% less call options, than puts
Call options by funds: $857K | Put options by funds: $2.35M
Holders
6
Holding in Top 10
–
Calls
$857K
Puts
$2.35M
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.78M | |
| 3 | +$27.9K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$21K |
Top Sellers
| 1 | -$358K | |
| 2 | -$181K | |
| 3 | -$175K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$33K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$2K |